594
Bearbeitungen
Änderungen
Zur Navigation springen
Zur Suche springen
Zeile 24:
Zeile 24: +
→Der Neuseeland-Ausschuss
''"Quadrivalent HPV (HPV4) vaccine (Gardasil, Merck) was approved by the FDA in June 2006. The vaccine is approved for females and males 9 through 26 years of age. Each 0.5-mL dose of HPV4 contains 20 micrograms HPV 6 L1 protein, 40 micrograms HPV 11 L1 protein, 40 micrograms HPV 16 L1 protein, and 20 micrograms HPV 18 L1 protein."''<ref> [https://www.cdc.gov/vaccines/pubs/pinkbook/hpv.html#hpv CDC Pinkbook HPV]</ref>
''"Quadrivalent HPV (HPV4) vaccine (Gardasil, Merck) was approved by the FDA in June 2006. The vaccine is approved for females and males 9 through 26 years of age. Each 0.5-mL dose of HPV4 contains 20 micrograms HPV 6 L1 protein, 40 micrograms HPV 11 L1 protein, 40 micrograms HPV 16 L1 protein, and 20 micrograms HPV 18 L1 protein."''<ref> [https://www.cdc.gov/vaccines/pubs/pinkbook/hpv.html#hpv CDC Pinkbook HPV]</ref>
===Behauptungen zu sterilisierendem Tetanus-Impfstoff in Kenia===
==Finanzierung==
==Finanzierung==